What is Give Legacy?
Give Legacy provides comprehensive at-home sperm testing and freezing solutions, enabling clients to take control of their reproductive health from the convenience of their homes. Their product suite includes sperm testing kits, STI test kits, male fertility supplements, and cryostorage services. These offerings are designed to be accessible, with HSA/FSA eligibility and financing options available. The company targets a diverse clientele, including individuals and families planning conception, LGBTQ+ families, those undergoing gender-affirming transition, and men facing medical conditions that could impact fertility. Give Legacy emphasizes ease of access through free 2-day shipping and insurance eligibility checks.
How much funding has Give Legacy raised?
Give Legacy has raised a total of $46M across 4 funding rounds:
Angel/Seed
$3.5M
Series A
$10M
Series B
$25M
Other Financing Round
$7.5M
Angel/Seed (2020): $3.5M with participation from Bain Capital LP, Section 32, and Y Combinator
Series A (2021): $10M led by FirstMark Capital LLC
Series B (2022): $25M supported by Valor Equity Partners, TQ Ventures, FirstMark Capital, Bain Capital Ventures, and Section 32
Other Financing Round (2024): $7.5M, investors not publicly disclosed
Key Investors in Give Legacy
FirstMark Capital LLC
FirstMark Capital is a venture capital firm known for investing in technology companies. Their involvement suggests a focus on scalable technology platforms within the healthcare or consumer sectors.
Valor Equity Partners
Valor Equity Partners is a private equity firm that invests in companies with strong growth potential. Their participation indicates a belief in Give Legacy's business model and its capacity for significant market impact.
TQ Ventures
TQ Ventures is a venture capital firm that seeks out founders with durable competitive advantages, often in B2B and B2C models. Their investment in Give Legacy points to an appreciation for the company's unique market approach and founder vision.
What's next for Give Legacy?
The recent major strategic investment in Give Legacy signals a pivotal moment for the company, likely enabling expansion of its service offerings, enhancement of its technological infrastructure, and broader market penetration. With a focus on at-home fertility solutions, Give Legacy is well-positioned to capitalize on the growing demand for personalized and accessible reproductive healthcare. Future growth may involve strategic partnerships, further product development in areas like genetic testing or advanced cryopreservation techniques, and scaling operations to meet increasing consumer needs.
See full Give Legacy company page
